Financial Tearsheet






Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Chart

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases

29 Nov 22
Cronos Group Inc. to Speak at Stifel Canada’s 3rd Annual Future of Healthcare Conference
TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Officer, will speak at Stifel Canada’s 3 rd Annual Future of
14 Nov 22
Cronos Group Appoints James Holm as Chief Financial Officer
TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of James Holm as Chief Financial Officer, effective immediately. Mr.
07 Nov 22
Cronos Group Reports 2022 Third Quarter Results
Reported consolidated net revenue increased 3% year-over-year to $20.9 million; on a constant currency basis, consolidated net revenue increased 7% year-over-year to $21.8 million Reported net revenue in Israel increased 88% year-over-year to $7.0 million; on a constant currency basis, net revenue

SEC Filings

Filing date Description

Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Events

07 December 2022 at 1:00 PM EST
Stifel Canada’s 3rd Annual Future of Healthcare Conference
07 November 2022 at 8:30 AM EST
Cronos Group Third Quarter 2022 Earnings Conference Call
09 August 2022 at 8:30 AM EDT
Cronos Group Second Quarter 2022 Earnings Conference Call